Opus Genetics Inc.

NASDAQ: IRD
Share price (10/21/25): $2.01
Market cap (10/21/25): $120 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration – amended

Prospectus supplement for primary offering

Ownership Filter

Gagnon Robert E.

Gagnon Robert E.

Nantahala Capital Management, LLC

News Filter

Reports Positive Pediatric Data From OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5

Appoints Rob Gagnon as Chief Financial Officer

Unregistered Sales of Equity Securities

Announces Financial Results for Second Quarter 2025 and Provides Corporate Update

Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindness

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Letter to shareholders

Additional info about upcoming vote

Proxy materials by non-management

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC